Targeting metabolic reprogramming to overcome drug resistance in advanced bladder cancer: insights from gemcitabine‐ and cisplatin‐resistant models
Ichiro Kawahara(Kagoshima University), Hideki Enokida(Kagoshima University Hospital)
Cited by 8
Related Papers
Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer
|British Journal of Cancer|2016|180
Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer
|International Journal of Oncology|2014|86
EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer
|BMC Cancer|2021|63
Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients
|Cancer Science|2020|48
Potential tumor‑suppressive role of microRNA‑99a‑3p in sunitinib‑resistant renal cell carcinoma cells through the regulation of RRM2
|International Journal of Oncology|2019|47